Healthcare Simulation Market by Product and Service (Anatomical Models, Patient Simulators (High Fidelity, Low Fidelity), Task Trainer, Surgical Simulators, Software, Services), End User (Academic Institutes, Hospital) & Region - Global Forecast to 2027
Updated on : April 18, 2023
The global healthcare simulation market in terms of revenue was estimated to be worth $1.9 billion in 2022 and is poised to reach $4.2 billion by 2027, growing at a CAGR of 16.1% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The major factors driving the growth of this market includes the need to maintain regulatory compliance, rising need to curtail healthcare costs, and growing demand for patient-centric healthcare. However, dearth of skilled IT professionals, and security concerns is challenging the growth of the global medical simulation market to a certain extent.
To know about the assumptions considered for the study, Request for Free Sample Report
Healthcare Simulation Market Dynamics
Driver: Increasing focus on patient safety
The increased adoption of simulation-based training and certification of healthcare professionals is an efficient means to improve patient safety and outcomes. This would result in a significantly larger addressable market than the current market, which is primarily education-based. According to a 2019 article published by the WHO, about 2.6 million people die every year in low- and middle-income countries due to patient harm in healthcare, making it the 14th leading cause of morbidity and mortality. Most detrimental errors are related to diagnosis and treatments. Training through simulation can help clinicians gain confidence, knowledge, and expertise for improving patient safety in a risk-free environment. Moreover, the Accreditation Council for Graduate Medical Education is evolving toward outcome-based assessment with specific benchmarks to measure and compare performance, which favors the adoption of simulation products and training.
The rising number of medical errors and the need to ensure patient safety and high-quality care have become key priorities for healthcare organizations worldwide. According to a 2019 article from the WHO, unsafe surgical care procedures cause complications in about 25% of patients globally. Also, according to the University Health Network, preventable medical errors killed more than 28,000 Canadians in 2019. As per the Journal of Patient Safety, in the US, between 210,000 and 440,000 fatalities occur each year due to preventable medical errors; they accounted for one-sixth of the annual deaths in the US in 2019. The cost of these errors is around USD 1 trillion annually. The global medication error reporting market was worth ~USD 326 million in 2018. Of this, one-third was due to knowledge-based errors.
Opportunity: Growing awareness about simulation training in emerging economies
Simulation for medical education in well-resourced settings has grown exponentially but remains uncommon in low-income countries. Emerging countries, such as Brazil, India, China, and South Africa, are expected to provide immense growth opportunities for the players operating in the healthcare simulation market. According to the World Bank Group, healthcare spending in low- and middle-income countries has increased from 5.01% in 2011 to 5.32% in 2019. More than half the world’s population resides in India and China, and these markets are home to a large patient base. The growing economy, rising private investments, untapped rural sector; rising prevalence of non-communicable lifestyle-related diseases; increasing focus on medical education, training, and research; and the growing number of academic medical institutions are the key factors driving the growth of the market in these countries.
The growth of the healthcare industry in emerging countries is also driven by rising government investments in healthcare and increasing public-private partnerships in medicine, which provide a favorable environment for the healthcare simulation market. Several new projects have been undertaken in emerging countries to provide high-quality training environments for medical professionals. For instance, China has invested in constructing a 15-km Beijing International Medical Centre, including a medical university, business school of medicine, international nursing hospital, medical simulation training center, and national clinical drug testing research center. This world-class project is expected to be completed by 2023 and will be the largest medical center in the world. This center will be equipped with simulation labs to train medical professionals on advanced and complex medical procedures. Such developments in emerging countries are expected to provide opportunities for growth in the medical simulation market.
Restraint: Poorly designed medical simulators
Simulation in healthcare creates a safe learning environment that allows researchers and practitioners to test new clinical processes and enhance individual and team skills before encountering patients. Many simulation applications involve manikins in which symptoms can be induced that respond to the simulated treatment. However, human systems are very complex, and therefore, models and instruments cannot completely match human functioning. The simulation models have to be constructed and manipulated by facilitators and simulation engineers to replicate a physiological response that is desired under specific circumstances. Manipulating these systems in accordance with the desired simulation goals is often cumbersome.
Poorly designed simulators might lead to negative learning, which can further lead to medical errors in judgments in the future. For instance, if physical and physiological symptoms are missing in the simulation, students may neglect to check for these symptoms. Simulation-based learning may also encourage shortcuts, such as omitting patient consent and safety procedures and may foster artificial rather than genuine communication skills. Participants will always approach a simulator differently from real life, which affects the attitude of learners. Two common changes in attitude can occur—hypervigilance, which causes excessive concern because one knows an event is about to occur, and cavalier behavior, which occurs because it is clear no human life is at stake. These factors may affect the growth of the market to an extent.
Challenge: Operational challenges
Most medical procedures involve interactions with various tissues. Tissues are usually heterogeneous and exhibit highly non-linear and anisotropic activities. A successful medical model must be computable instantaneously so that its responses to operator inputs are instantly accessible. For instance, in a simple incision process, the scalpel passes through the skin (which comprises different tissues), then through the adipose tissue, muscle tissue, and into or through an organ. In this case, the scalpel will cause blood vessels to release blood. Going forward, the scalpel will pass through more than ten different tissues. In each case, the tissue responses (visual, haptic, and olfactory) must be appropriate for enabling a more realistic medical training environment. The application of physics-based modeling and simulation approaches to tissue modeling can develop more realistic behaviors in patients. However, they lack the sensitivity to produce a real-time performance of various types of tissues.
Healthcare practitioners have to implement a multidisciplinary approach to tackle critical medical conditions. Simulators are required to be multimodal to demonstrate critical conditions. Although the latest technologies, such as virtual reality and haptic technology, have improved medical simulation and training of healthcare practitioners to a certain level, a multidisciplinary approach is not achievable in certain areas of medical treatments, such as complex situations in neurosurgeries.
The web-based simulation segment registered the highest growth in the healthcare simulation market, by product & service
On the basis of type, Based on the type, the web-based simulation segment registered the highest growth of this market during the forecast period. Factors responsible for the growth of this segment is the controlled and predictable learning environments, and controlled access to simulation procedures.
Hospitals registered highest growth by the end user of healthcare simulation market
Hospitals segment is projected to grow at the highest growth rate of this market. The increasing focus on patient safety and the growing demand for minimally invasive surgeries are the factors attributed to the growth of the segment.
North America accounted for the largest share of the healthcare simulation market during the forecast period.
North America holds the largest share of this market. Growth in the North American medical simulation market can be attributed to factors such growing access to technologies, well-established distribution channels, the rising number of healthcare professionals demanding hands-on patient training, and the rise in demand for virtual and online training, and the presence of leading market players in the region.
To know about the assumptions considered for the study, download the pdf brochure
The healthcare simulation market is dominated by a few globally established players such as CAE (Canada), Laerdal Medical (Norway), Gaumard Scientific Co. (US), Limbs & Things (UK), Surgical Science Sweden AB (Sweden), Kyoto Kagaku (Japan), Mentice AB (Sweden), Intelligent Ultrasound Group Plc (UK), Simulab Corp. (US), Simulaids (US), Operative Experience Inc. (US), Cardionics Inc. (US), VirtaMed AG (Switzerland), Altay Scientific (Italy), IngMar Medical (US), TruCorp Ltd. (Ireland), Medical-X (Netherlands), KaVo Dental GmbH (Germany), Simendo B.V. (Netherlands), VRMagic Holding AG (Germany), Symgery (Canada), HRV Simulation (France), Synaptive Medical (Canada), and Inovus Medical (UK).
Healthcare Simulation Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2022 |
$1.9 billion |
|
Projected Revenue by 2027 |
$4.2 billion |
|
Revenue Rate |
Poised to grow at a CAGR of 16.1% |
|
Market Driver |
Increasing focus on patient safety |
|
Market Opportunity |
Growing awareness about simulation training in emerging economies |
This study categorizes the global Healthcare Simulation Market to forecast revenue and analyze trends in each of the following submarkets:
By Product & Service
-
Medical Simulation Anatomical Models
-
Patient Simulators
- High Fidelity Simulators
- Medium Fidelity Simulators
- Low Fidelity Simulators
- Task Trainer
-
Interventional Surgical Simulators
- Laparoscopic Surgical Simulators
- Gynecology Simulators
- Cardiovascular Simulators
- Orthopedic Simulators
- Spine Surgical Simulators
- Other Interventional /Surgical Simulators
- Endovascular Simulators
- Ultrasound Simulators
- Dental Simulators
- Eye Simulators
-
Patient Simulators
- Web-Based Simulation
- Medical Simulation Software
-
Simulation Training Services
- Vendor Based Training
- Education Societies
- Custom Consulting Services
By End User
- Introduction
- Academic institutes
- Hospitals
- Military Organizations
- Other End Users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Italy
- Spain
- RoE
-
Asia Pacific
- Japan
- China
- India
- RoAPAC
-
Latin America
- Brazil
- Mexico
- RoLATAM
- Middle East & Africa
Recent Developments:
- In August 2021, Surgical Science Sweden AB acquired Simbionix (US) to provide the highest standard in training for medical professionals with their respective technologies.
- In July 2021, CAE Inc. partnered with Rush Center for Clinical Skills and Simulation (RCCSS) to help the companies improve patient safety and enhance healthcare education.
- In June 2021, Mentice AB collaborated with Thomas Jefferson University Hospitals to establish a Simulation Center of Excellence to elevate and promote clinical training and introduce advanced Virtual Reality-based simulation solutions for physicians.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global healthcare simulation market?
The global healthcare simulation market boasts a total revenue value of $4.2 billion by 2027.
What is the estimated growth rate (CAGR) of the global healthcare simulation market?
The global market for healthcare simulation has an estimated compound annual growth rate (CAGR) of 16.1% and a revenue size in the region of $1.9 billion in 2022.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 32)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION AND SCOPE
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKET SEGMENTATION
FIGURE 1 HEALTHCARE SIMULATION MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED
1.3 CURRENCY
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 36)
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
FIGURE 2 HEALTHCARE SIMULATION MARKET: RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION: HEALTHCARE SIMULATION MARKET
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 REVENUE ANALYSIS OF TOP 3 PUBLIC COMPANIES: MEDICAL SIMULATION MARKET (2021)
FIGURE 8 BOTTOM-UP APPROACH: SEGMENTAL EXTRAPOLATION
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: MEDICAL SIMULATION MARKET
3 EXECUTIVE SUMMARY (Page No. - 50)
FIGURE 12 HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 13 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 MEDICAL SIMULATION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 15 MEDICAL SIMULATION MARKET: REGIONAL SNAPSHOT
4 PREMIUM INSIGHTS (Page No. - 53)
4.1 HEALTHCARE SIMULATION MARKET OVERVIEW
FIGURE 16 ADVANCEMENTS IN MEDICAL TECHNOLOGIES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021)
FIGURE 17 MEDICAL SIMULATION ANATOMICAL MODELS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021
4.3 MEDICAL SIMULATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
4.4 REGIONAL MIX: HEALTHCARE SIMULATION MARKET
FIGURE 19 NORTH AMERICA TO DOMINATE MEDICAL SIMULATION MARKET DURING FORECAST PERIOD
4.5 MEDICAL SIMULATION MARKET: DEVELOPING VS. DEVELOPED COUNTRIES
FIGURE 20 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 58)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 HEALTHCARE SIMULATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 MARKET DYNAMICS: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Limited access to patients during medical training
5.2.1.2 Rising technological advancements in medical education
5.2.1.3 Growing demand for minimally invasive treatments
FIGURE 22 TOTAL CASE NUMBERS REPORTED BY GENERAL SURGERY RESIDENTS FOR OPEN SURGERIES: 16-YEAR ANALYSIS (2003–2019)
FIGURE 23 TOTAL CASE NUMBERS REPORTED BY GENERAL SURGERY RESIDENTS FOR LAPAROSCOPIC SURGERIES: 16-YEAR ANALYSIS (2003–2019)
5.2.1.4 Increasing focus on patient safety
FIGURE 24 GLOBAL MEDICATION ERROR REPORTING MARKET SHARE, 2018 VS. 2026
5.2.1.5 Growing preference for virtual interaction
5.2.2 RESTRAINTS
5.2.2.1 Limited availability of funds
5.2.2.2 Poorly designed medical simulators
5.2.3 OPPORTUNITIES
5.2.3.1 Shortage of healthcare personnel
5.2.3.2 Growing awareness about simulation training in emerging economies
5.2.4 CHALLENGES
5.2.4.1 High cost of simulators
5.2.4.2 Operational challenges
6 INDUSTRY INSIGHTS (Page No. - 66)
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 USE OF VIRTUAL REALITY (VR) AND AUGMENTED REALITY (AR) IN MEDICAL SIMULATION
6.2.2 HIGH-FIDELITY TECHNOLOGICAL ADVANCEMENTS
6.2.3 MULTIMODAL APPROACH IN DEVELOPMENT OF SIMULATORS
6.2.4 UTILIZATION OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING SOFTWARE IN SURGICAL PROCEDURES
6.2.5 GROWING USE OF HCIT/EMR
6.3 REGULATORY ANALYSIS
6.3.1 MEDICAL SIMULATION PRODUCTS
6.3.1.1 North America
6.3.1.1.1 US
TABLE 3 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
6.3.1.1.1 Canada
6.3.1.2 Europe
6.3.1.3 Asia Pacific
6.3.1.3.1 Japan
TABLE 4 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN
6.3.1.3.2 China
TABLE 5 NMPA MEDICAL DEVICE CLASSIFICATION
6.3.1.3.3 India
6.3.2 INTEROPERABILITY STANDARDS
TABLE 6 KEY STANDARDS FOR INTEROPERABILITY IN DIGITAL HEALTH SPECTRUM
TABLE 7 QUALITATIVE ANALYSIS OF WIDELY USED DATA TRANSMISSION STANDARDS IN DIGITAL HEALTH SPECTRUM
6.3.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.4 PORTER’S FIVE FORCES ANALYSIS
TABLE 9 PORTER’S FIVE FORCES ANALYSIS
6.4.1 THREAT OF NEW ENTRANTS
6.4.2 THREAT OF SUBSTITUTES
6.4.3 BARGAINING POWER OF SUPPLIERS
6.4.4 BARGAINING POWER OF BUYERS
6.4.5 INTENSITY OF COMPETITIVE RIVALRY
6.5 PRICING ANALYSIS
TABLE 10 PRICE RANGE FOR MEDICAL SIMULATION SOLUTIONS
6.6 TECHNOLOGY ANALYSIS
6.7 ECOSYSTEM ANALYSIS
6.7.1 MEDICAL SIMULATION MARKET: ECOSYSTEM ANALYSIS
6.8 PATENT ANALYSIS
6.8.1 PATENT PUBLICATION TRENDS FOR MEDICAL SIMULATION
FIGURE 25 PATENT PUBLICATION TRENDS (JANUARY 2012–AUGUST 2022)
6.8.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 26 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR MEDICAL SIMULATION PATENTS (JANUARY 2012 TO AUGUST 2022)
FIGURE 27 TOP APPLICANT COUNTRIES/REGIONS FOR MEDICAL SIMULATION PATENTS (JANUARY 2012 TO AUGUST 2022)
6.9 VALUE CHAIN ANALYSIS
FIGURE 28 MEDICAL SIMULATION MARKET: VALUE CHAIN ANALYSIS
6.10 CASE STUDY
6.11 KEY CONFERENCES AND EVENTS
TABLE 11 HEALTHCARE/MEDICAL SIMULATION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 29 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 END USERS
TABLE 12 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 END USERS
6.12.2 BUYING CRITERIA
FIGURE 30 KEY BUYING CRITERIA FOR TOP 3 END USERS
TABLE 13 KEY BUYING CRITERIA FOR TOP 3 END USERS
7 HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE (Page No. - 87)
7.1 INTRODUCTION
TABLE 14 HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
7.2 MEDICAL SIMULATION ANATOMICAL MODELS
TABLE 15 MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 16 MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1 PATIENT SIMULATORS
TABLE 17 PATIENT SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 18 PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 19 PATIENT SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1.1 High-fidelity simulators
7.2.1.1.1 Growing adoption of high-fidelity simulators in educational training to drive growth
TABLE 20 HIGH-FIDELITY SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 21 HIGH-FIDELITY PATIENT SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1.2 Medium-fidelity simulators
7.2.1.2.1 Cost benefits of medium-fidelity simulation to drive demand
TABLE 22 MEDIUM-FIDELITY SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 23 MEDIUM-FIDELITY PATIENT SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1.3 Low-fidelity simulators
7.2.1.3.1 Budgetary constraints and ease of use to drive demand
TABLE 24 LOW-FIDELITY SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 25 LOW-FIDELITY PATIENT SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2 TASK TRAINERS
7.2.2.1 Inability to imitate emotional attributes of patients to restrain growth
TABLE 26 TASK TRAINERS OFFERED BY KEY MARKET PLAYERS
TABLE 27 TASK TRAINERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3 INTERVENTIONAL/SURGICAL SIMULATORS
TABLE 28 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 29 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
7.2.3.1 Laparoscopic surgical simulators
7.2.3.1.1 Increasing preference for minimally invasive surgeries to drive growth
TABLE 30 LAPAROSCOPIC SURGICAL SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 31 LAPAROSCOPIC SURGICAL SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.2 Gynecology simulators
7.2.3.2.1 Increasing incidence of fibroids and polyps in women to drive demand for gynecology simulators
TABLE 32 GYNECOLOGY SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 33 GYNECOLOGY SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.3 Cardiovascular simulators
7.2.3.3.1 Increasing prevalence of obesity and diabetes to boost demand
TABLE 34 CARDIOVASCULAR SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 35 CARDIOVASCULAR SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.4 Orthopedic surgical simulators
7.2.3.4.1 Growing number of orthopedic surgeries to drive demand
TABLE 36 ORTHOPEDIC SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 37 ORTHOPEDIC SURGICAL SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.5 Spine surgical simulators
7.2.3.5.1 Increasing incidence of spinal injuries to boost growth
TABLE 38 SPINE SURGICAL SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 39 SPINE SURGICAL SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.6 Other surgical simulators
TABLE 40 OTHER SURGICAL SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 41 OTHER SURGICAL SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.4 ENDOVASCULAR SIMULATORS
7.2.4.1 Endovascular simulators help in reducing mortality rates
TABLE 42 ENDOVASCULAR SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 43 ENDOVASCULAR SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.5 ULTRASOUND SIMULATORS
7.2.5.1 Inferior quality images resulting from low dynamics and spatial resolution to restrain growth
TABLE 44 ULTRASOUND SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 45 ULTRASOUND SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.6 DENTAL SIMULATORS
7.2.6.1 Expanding dental tourism industry to drive growth
TABLE 46 DENTAL SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 47 DENTAL SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.7 EYE SIMULATORS
7.2.7.1 Increasing incidence of eye disorders to drive growth
TABLE 48 EYE SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 49 EYE SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 WEB-BASED SIMULATION
7.3.1 RISING TECHNOLOGICAL ADVANCEMENTS DRIVING ADOPTION OF WEB-BASED SIMULATION
TABLE 50 WEB-BASED SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 51 WEB-BASED SIMULATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 MEDICAL SIMULATION SOFTWARE
7.4.1 KEY ADVANTAGES OFFERED BY MEDICAL SIMULATION SOFTWARE TO DRIVE ADOPTION
TABLE 52 MEDICAL SIMULATION SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 53 MEDICAL SIMULATION SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 SIMULATION TRAINING SERVICES
TABLE 54 MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 55 MEDICAL SIMULATION TRAINING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.5.1 VENDOR-BASED TRAINING
7.5.1.1 High focus on patient safety to drive demand
TABLE 56 VENDOR-BASED TRAINING SERVICES OFFERED BY KEY MARKET PLAYERS
TABLE 57 VENDOR-BASED TRAINING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.5.2 EDUCATIONAL SOCIETIES
7.5.2.1 Growing need for proper training and authenticity of knowledge to drive growth
TABLE 58 EDUCATIONAL SOCIETIES SIMULATORS OFFERED BY KEY MARKET PLAYERS
TABLE 59 EDUCATIONAL SOCIETIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.5.3 CUSTOM CONSULTING SERVICES
7.5.3.1 Growing need to limit errors associated with traditional medical training systems to drive growth
TABLE 60 CUSTOM CONSULTING SERVICES OFFERED BY KEY MARKET PLAYERS
TABLE 61 CUSTOM CONSULTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 HEALTHCARE SIMULATION MARKET, BY END USER (Page No. - 126)
8.1 INTRODUCTION
TABLE 62 MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 ACADEMIC INSTITUTES
8.2.1 GROWING NEED FOR SKILLED MEDICAL PROFESSIONALS TO DRIVE DEMAND
TABLE 63 MEDICAL SIMULATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 HOSPITALS
8.3.1 RISING FOCUS ON MINIMIZING MEDICAL ERRORS TO DRIVE DEMAND
TABLE 64 MEDICAL SIMULATION MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 MILITARY ORGANIZATIONS
8.4.1 FOCUS ON EXPLORING NEW METHODS OF MEDICAL CARE DURING WARFARE TO DRIVE DEMAND
TABLE 65 MEDICAL SIMULATION MARKET FOR MILITARY ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 OTHER END USERS
TABLE 66 MEDICAL SIMULATION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
9 HEALTHCARE SIMULATION MARKET, BY REGION (Page No. - 133)
9.1 INTRODUCTION
TABLE 67 MEDICAL SIMULATION MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 31 NORTH AMERICA: HEALTHCARE SIMULATION MARKET SNAPSHOT (2021)
TABLE 68 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 69 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 70 NORTH AMERICA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 NORTH AMERICA: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 NORTH AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 73 NORTH AMERICA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Increasing demand for virtual tutors and high healthcare spending to boost growth
TABLE 75 US: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 76 US: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 US: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 78 US: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 79 US: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 80 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Increasing funding and surgical capabilities to drive growth
TABLE 81 CANADA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 82 CANADA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 CANADA: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 84 CANADA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 85 CANADA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 CANADA: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 87 EUROPE: hEALTHCARE SIMULATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 88 EUROPE: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 89 EUROPE: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 90 EUROPE: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 EUROPE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 EUROPE: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 EUROPE: HEALTHCARE SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 UK
9.3.1.1 Rising number of healthcare simulation centers and hospitals to drive growth
TABLE 94 UK: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 95 UK: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 UK: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 UK: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 UK: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 UK: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Growing focus on use of innovative methods in medical training to drive growth
TABLE 100 FRANCE: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 101 FRANCE: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 FRANCE: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 FRANCE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 FRANCE: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 FRANCE: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 GERMANY
9.3.3.1 High healthcare spending to drive growth
TABLE 106 GERMANY: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 107 GERMANY: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 108 GERMANY: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 GERMANY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 GERMANY: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 GERMANY: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Shortage of trained healthcare personnel to drive growth
TABLE 112 ITALY: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 113 ITALY: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 114 ITALY: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 ITALY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 ITALY: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 ITALY: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing number of surgical procedures to boost growth
TABLE 118 SPAIN: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 119 SPAIN: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 SPAIN: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 121 SPAIN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 SPAIN: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 SPAIN: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 124 ROE: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 125 ROE: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 126 ROE: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 ROE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 128 ROE: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 ROE: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 32 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET SNAPSHOT (2021)
TABLE 130 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 131 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 132 ASIA PACIFIC: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 ASIA PACIFIC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 135 ASIA PACIFIC: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Increasing demand for virtual tutors and technologically advanced simulators to drive growth
TABLE 137 JAPAN: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 138 JAPAN: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 JAPAN: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 JAPAN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 141 JAPAN: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 142 JAPAN: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Increasing demand for trained medical professionals to drive growth
TABLE 143 CHINA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 144 CHINA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 CHINA: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 CHINA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 CHINA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 148 CHINA: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing awareness regarding patient safety due to healthcare negligence to drive growth
TABLE 149 INDIA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 150 INDIA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 INDIA: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 INDIA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 INDIA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 INDIA: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 155 ROAPAC: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 156 ROAPAC: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 157 ROAPAC: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 ROAPAC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 ROAPAC: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 ROAPAC: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
TABLE 161 LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 162 LATIN AMERICA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 163 LATIN AMERICA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 164 LATIN AMERICA: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 LATIN AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 LATIN AMERICA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 167 LATIN AMERICA: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 High incidence of chronic diseases to drive growth
TABLE 168 BRAZIL: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 169 BRAZIL: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 BRAZIL: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 BRAZIL: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 BRAZIL: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 173 BRAZIL: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Disruptive technologies and public-private partnerships to boost growth
TABLE 174 MEXICO: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 175 MEXICO: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 176 MEXICO: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 177 MEXICO: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 MEXICO: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 MEXICO: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 180 ROLA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 181 ROLA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 182 ROLA: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 183 ROLA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 ROLA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 185 ROLA: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE GROWTH
TABLE 186 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 187 MIDDLE EAST & AFRICA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 188 MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 189 MIDDLE EAST & AFRICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 190 MIDDLE EAST & AFRICA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 191 MIDDLE EAST & AFRICA: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 199)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 192 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2019 AND SEPTEMBER 2022
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
10.4 MARKET SHARE ANALYSIS
FIGURE 34 MEDICAL SIMULATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
10.4.1 SURGICAL SIMULATORS MARKET RANKING ANALYSIS
FIGURE 35 SURGICAL SIMULATORS MARKET RANKING ANALYSIS, BY KEY PLAYER, 2021
10.5 COMPETITIVE LEADERSHIP MAPPING
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 36 HEALTHCARE SIMULATION MARKET: COMPETITIVE LEADERSHIP MAPPING FOR KEY PLAYERS (2021)
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 37 HEALTHCARE SIMULATION MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2021)
10.7 COMPETITIVE SCENARIO
TABLE 194 KEY DEALS, JANUARY 2019 TO SEPTEMBER 2022
TABLE 195 OTHER KEY DEVELOPMENTS, JANUARY 2019 TO SEPTEMBER 2022
10.8 COMPETITIVE BENCHMARKING
TABLE 196 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 197 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
11 COMPANY PROFILES (Page No. - 213)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 CAE INC.
TABLE 198 CAE INC.: BUSINESS OVERVIEW
FIGURE 38 CAE INC.: COMPANY SNAPSHOT (2021)
11.1.2 LAERDAL MEDICAL
TABLE 199 LAERDAL MEDICAL: BUSINESS OVERVIEW
11.1.3 GAUMARD SCIENTIFIC CO.
TABLE 200 GAUMARD SCIENTIFIC: BUSINESS OVERVIEW
11.1.4 KYOTO KAGAKU
TABLE 201 KYOTO KAGAKU: BUSINESS OVERVIEW
11.1.5 LIMBS & THINGS
TABLE 202 LIMBS & THINGS: BUSINESS OVERVIEW
11.1.6 MENTICE AB
TABLE 203 MENTICE AB: BUSINESS OVERVIEW
FIGURE 39 MENTICE AB: COMPANY SNAPSHOT (2021)
11.1.7 SIMULAB CORPORATION
TABLE 204 SIMULAB CORPORATION: BUSINESS OVERVIEW
11.1.8 SIMULAIDS
TABLE 205 SIMULAIDS: BUSINESS OVERVIEW
11.1.9 INTELLIGENT ULTRASOUND GROUP PLC
TABLE 206 INTELLIGENT ULTRASOUND GROUP PLC.: BUSINESS OVERVIEW
FIGURE 40 INTELLIGENT ULTRASOUND GROUP PLC: COMPANY SNAPSHOT (2021)
11.1.10 OPERATIVE EXPERIENCE INC.
TABLE 207 OPERATIVE EXPERIENCE INC.: BUSINESS OVERVIEW
11.1.11 SURGICAL SCIENCE SWEDEN AB
TABLE 208 SURGICAL SCIENCE SWEDEN AB: BUSINESS OVERVIEW
FIGURE 41 SURGICAL SCIENCE SWEDEN AB: COMPANY SNAPSHOT (2021)
11.1.12 CARDIONICS INC. (SUBSIDIARY OF 3B SCIENTIFIC)
TABLE 209 CARDIONICS INC.: BUSINESS OVERVIEW
11.1.13 VIRTAMED AG
TABLE 210 VIRTAMED AG: BUSINESS OVERVIEW
11.1.14 SYNBONE AG
TABLE 211 SYNBONE AG: BUSINESS OVERVIEW
11.1.15 INGMAR MEDICAL
TABLE 212 INGMAR MEDICAL: BUSINESS OVERVIEW
11.1.16 MEDICAL-X
TABLE 213 MEDICAL-X: BUSINESS OVERVIEW
11.1.17 KAVO DENTAL GMBH
TABLE 214 KAVO DENTAL GMBH: BUSINESS OVERVIEW
11.1.18 ALTAY SCIENTIFIC
TABLE 215 ALTAY SCIENTIFIC: BUSINESS OVERVIEW
11.1.19 TRUCORP LTD.
TABLE 216 TRUCORP LTD.: BUSINESS OVERVIEW
11.1.20 SIMENDO B.V.
TABLE 217 SIMENDO B.V.: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 HAAG-STREIT SIMULATION
11.2.2 SYMGERY
11.2.3 HRV SIMULATION
11.2.4 SYNAPTIVE MEDICAL
11.2.5 INOVUS MEDICAL
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 301)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
This research study involved the extensive use of both primary and secondary sources. Various factors affecting the industry were studied to identify segmentation types; industry trends; key players; the competitive landscape of the market; and key market dynamics, such as drivers, restraints, opportunities, challenges, and key player strategies.
Secondary Research
This research study involved the use of secondary sources; directories; databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers; annual reports; and Companies’ House documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the healthcare simulation market. It was also used to obtain important information about the top players, market classification, segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information. The primary sources from the supply side include CEOs, vice presidents & managing directors, marketing heads, directors and sales directors, marketing managers, regional/area sales managers, product managers, technology experts of medical simulation software solutions. Primary sources from the demand side include industry experts such as directors of hospitals, academic institutes, military organizations, and emergency care centers.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, and product managers.
Note: Tiers are defined based on a company’s total revenue, as of 2020: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 =
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the healthcare simulation market was arrived at after data triangulation from three different approaches, as mentioned below. After each approach, the weighted average of approaches was taken based on the level of assumptions used.
Data Triangulation
The size of the healthcare simulation market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as given below:
- Major players across the endovascular simulators segment were determined through secondary sources (validated through primary respondents).
- The approximate revenue share of top players, such as Mentice AB, in the endovascular simulators segment was collected through secondary sources.
- The total share of the endovascular simulators segment was determined in the medical simulation anatomical models segment to derive its revenue.
The total revenue in the global healthcare simulation market was determined by extrapolating the medical simulation anatomical models segment revenue.
Global Healthcare Simulation Market Size: Top-Down Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Objectives of the Study
- To define, describe, and forecast the medical simulation market based on product & service, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to the individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa (along with country-wise segmentation)
- To profile the key players and comprehensively analyze their market shares and core competencies2 in the medical simulation market
- To track and analyze competitive developments such as partnerships, agreements, collaborations, alliances, mergers and acquisitions, new product developments, geographic expansions, and R&D activities in the medical simulation market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Europe healthcare simulation market into Denmark, Norway, and others
- Further breakdown of the Rest of Asia Pacific healthcare simulation market into Vietnam, Pakistan, New Zealand, Australia, South Korea, and others
Generating Response ...
Growth opportunities and latent adjacency in Healthcare Simulation Market
Which are the top companies hold the market share in medical simulation market?
What are the key trends in the healthcare simulation market report?